» Articles » PMID: 22137597

CCL2−2518 (A/G) Polymorphisms and Tuberculosis Susceptibility: a Meta-analysis

Overview
Specialty Pulmonary Medicine
Date 2011 Dec 6
PMID 22137597
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It has been found that the -2518 C-C motif ligand (CCL)-2 promoter variant increases the risk of developing active tuberculosis (TB).

Objective: To study the association between -2518 variants and susceptibility to TB.

Design: We searched Medline, PubMed and the Wan Fang databases for human genetic studies on whether the -2518 CCL2 polymorphism influences the expression of active TB. Articles published from January 1998 to November 2010 were included. A random effects model was conducted in the meta-analysis.

Results: The CCL2-2518G allele (OR 1.51, 95%CI 1.11-2.04, P = 0.008) showed significant association with susceptibility to TB. In genotype analysis, the recessive model (CCL2 genotype GG, OR 1.66, 95%CI 1.19-2.33, P = 0.003) was slightly superior to the dominant model (G carrier genotypes OR 1.53, 95%CI 1.07-2.17, P = 0.018). These observations were prominent among Asians and Latin-Americans of Hispanic ancestry, but not in Africans from Ghana and South Africa. The presence of epistatic genes in one population but not in the other, environmental differences and pathogen virulence may account for this.

Conclusion: The CCL2-2518G allele increases the risk of developing TB in Asians and Hispanics.

Citing Articles

A diagnostic model for distinguishing between active tuberculosis and latent tuberculosis infection based on the blood expression profiles of autophagy-related genes.

Wang C, Hua J, He X, Chen L, Lv S Ther Adv Respir Dis. 2023; 17:17534666231217798.

PMID: 38131281 DOI: 10.1177/17534666231217798.


Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis.

Sampath P, Rajamanickam A, Thiruvengadam K, Natarajan A, Hissar S, Dhanapal M Sci Rep. 2023; 13(1):7404.

PMID: 37149713 PMC: 10163852. DOI: 10.1038/s41598-023-34530-z.


Elucidating Mechanisms of Tolerance to Typhimurium across Long-Term Infections Using the Collaborative Cross.

Scoggin K, Gupta J, Lynch R, Nagarajan A, Aminian M, Peterson A mBio. 2022; 13(4):e0112022.

PMID: 35880881 PMC: 9426527. DOI: 10.1128/mbio.01120-22.


Can the personalized medicine approach contribute in controlling tuberculosis in general and India in particular?.

Khan N, Das A Precis Clin Med. 2022; 3(3):240-243.

PMID: 35694414 PMC: 8982531. DOI: 10.1093/pcmedi/pbaa021.


TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation.

Iizasa E, Chuma Y, Uematsu T, Kubota M, Kawaguchi H, Umemura M Nat Commun. 2021; 12(1):2299.

PMID: 33863908 PMC: 8052348. DOI: 10.1038/s41467-021-22620-3.